Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 3
2022 4
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis.
Yamada T, Hiramoto N, Mori T, Yamashita D, Tai Y, Yamamoto R, Nishikubo M, Maruoka H, Sakamoto K, Takeuchi K, Nannya Y, Ogawa S, Ishikawa T. Yamada T, et al. Among authors: nishikubo m. Blood Cancer J. 2023 Aug 9;13(1):119. doi: 10.1038/s41408-023-00893-9. Blood Cancer J. 2023. PMID: 37558659 Free PMC article. No abstract available.
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Okada Y, et al. Among authors: nishikubo m. Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837. Blood Adv. 2024. PMID: 38163321 Free PMC article.
Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma.
Nakaya Y, Nakamae H, Nishikubo M, Kondo E, Fukuda T, Hiramoto N, Mori Y, Nagafuji K, Eto T, Onishi Y, Uchida N, Ishikawa J, Matsuoka KI, Yui S, Takase K, Kawakita T, Kanda J, Ichinohe T, Atsuta Y, Kako S. Nakaya Y, et al. Among authors: nishikubo m. Bone Marrow Transplant. 2024 Feb 14. doi: 10.1038/s41409-024-02229-y. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38355911
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies.
Nishikubo M, Shimomura Y, Yamamoto R, Yoshioka S, Maruoka H, Nasu S, Nishioka T, Sakizono K, Mitsuyuki S, Kubo T, Okada N, Nakagawa D, Kamijo K, Imoto H, Nagai Y, Hiramoto N, Yonetani N, Kondo T, Miyakoshi C, Doi A, Ishikawa T. Nishikubo M, et al. Blood Cancer J. 2023 Jan 23;13(1):17. doi: 10.1038/s41408-023-00792-z. Blood Cancer J. 2023. PMID: 36690628 Free PMC article. No abstract available.
Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan.
Shimomura Y, Kitamura T, Nishikubo M, Sobue T, Uchida N, Doki N, Tanaka M, Ito A, Ishikawa J, Ara T, Ota S, Onizuka M, Sawa M, Ozawa Y, Maruyama Y, Ikegame K, Kanda Y, Ichinohe T, Fukuda T, Okamoto S, Teshima T, Atsuta Y. Shimomura Y, et al. Among authors: nishikubo m. Int J Hematol. 2023 Apr;117(4):590-597. doi: 10.1007/s12185-022-03508-4. Epub 2022 Dec 14. Int J Hematol. 2023. PMID: 36515796 Free PMC article.
Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancy.
Mitsuyuki S, Nishikubo M, Shimomura Y, Ohyama Y, Maruoka H, Nasu S, Kubo T, Suzuki Y, Okada N, Nakagawa D, Kamijo K, Yamamoto R, Nagai Y, Hiramoto N, Yoshioka S, Yonetani N, Hasegawa K, Kuroda H, Hasuike T, Doi A, Kondo T, Ishikawa T. Mitsuyuki S, et al. Among authors: nishikubo m. Eur J Haematol. 2023 Jul;111(1):57-62. doi: 10.1111/ejh.13967. Epub 2023 Mar 30. Eur J Haematol. 2023. PMID: 36965014
21 results